Team:Tianjin/Attributions
From 2011.igem.org
Line 90: | Line 90: | ||
margin-left:5px; | margin-left:5px; | ||
margin-top:17px; | margin-top:17px; | ||
- | width= | + | width=110px; |
height=41px; | height=41px; | ||
padding-top:41px; | padding-top:41px; | ||
- | padding-left: | + | padding-left:110px; |
display:block; | display:block; | ||
border-bottom:0px | border-bottom:0px | ||
Line 110: | Line 110: | ||
margin-left:5px; | margin-left:5px; | ||
margin-top:17px; | margin-top:17px; | ||
- | width= | + | width=110px; |
height=41px; | height=41px; | ||
padding-top:41px; | padding-top:41px; | ||
- | padding-left: | + | padding-left:110px; |
display:block; | display:block; | ||
border-bottom:0px | border-bottom:0px | ||
Line 130: | Line 130: | ||
margin-left:5px; | margin-left:5px; | ||
margin-top:17px; | margin-top:17px; | ||
- | width= | + | width=110px; |
height=41px; | height=41px; | ||
padding-top:41px; | padding-top:41px; | ||
- | padding-left: | + | padding-left:110px; |
display:block; | display:block; | ||
border-bottom:0px | border-bottom:0px | ||
Line 150: | Line 150: | ||
margin-left:5px; | margin-left:5px; | ||
margin-top:17px; | margin-top:17px; | ||
- | width= | + | width=110px; |
height=41px; | height=41px; | ||
padding-top:41px; | padding-top:41px; | ||
- | padding-left: | + | padding-left:110px; |
display:block; | display:block; | ||
border-bottom:0px | border-bottom:0px | ||
Line 170: | Line 170: | ||
margin-left:5px; | margin-left:5px; | ||
margin-top:17px; | margin-top:17px; | ||
- | width= | + | width=110px; |
height=41px; | height=41px; | ||
padding-top:41px; | padding-top:41px; | ||
- | padding-left: | + | padding-left:110px; |
display:block; | display:block; | ||
border-bottom:0px | border-bottom:0px |
Revision as of 06:37, 9 September 2011
Template:Https://2011.igem.org/Team:Peking S/bannerhidden Template:Https://2011.igem.org/Team:Peking S/back2
TaKaRa Biotechnology (Dalian) Co., Ltd. (TaKaRa Dalian), located in Dalian Economic and Technical Development Zone, is a subsidiary of TaKaRa Bio Inc (TBI), the leading Japanese manufacture of reagents for use in genetic engineering research. TaKaRa Bio Group is one of the three largest bioengineering companies in the world and its products supply over 60% of the Japanese biomedical market and are much in demand around the world. TaKaRa Dalian was established in 1993 and its products and services include production of restriction enzymes, modifying enzymes, molecular biology kits, PCR kits, provision of DNA synthesis and sequencing, gene synthesis, site specific mutagenesis and DNA chip manufacturing services. Moreover, our first class laboratories enable us to provide you with the best conditions for your research. 'High Quality Products & Rapid Reliable Service' are our shared values. Our mission is to be the premiere genetic products supply enterprise. Our distributors present in over 20 Chinese cities, are ready to serve you at any time. TaKaRa is close in hand. We continue to pursue technological innovation, business expansion and improved customer services in keeping with this new genomic age. TaKaRa----your reliable friend, your best choice, forever…